17.03.2023 • NewsOqemaChemical Distributiondistribution

Oqema expands its business through the acquisition of Stera Chemicals

Oqema has announced its acquisition of Stera Chemicals, one of the largest distributors of chemical raw materials in Romania.

This strategic move will not only expand Oqema's product portfolio, but also strengthen its service infrastructure in Southeast Europe (SEE) and its specialties footprint.

Stera Chemicals has a remarkable success story, having grown from a startup with only two employees and a laboratory to become one of the largest distributors of raw materials in the Romanian market. With a portfolio of over 1,000 products, Stera Chemicals serves more than 1,100 customers and operates as a major gateway to East and South East Europe.

The acquisition of Stera Chemicals is a significant milestone for Oqema, as it will enable the company to better serve specialty customers in the SEE region and beyond with an expanded product range. Furthermore, Stera Chemicals' operational excellence, with 90% of all orders shipped and received the next day, strengthens Oqema's customer-oriented culture and will enhance the company's overall service offering.

The founder and current owner of Stera Chemicals, Alecsandru Rasidescu, will continue to lead the business as managing director jointly with László Piry, Regional Head SEE, and Zsolt Bara, Managing Director Oqema Romania.

Oqema has acquired Stera Chemicals © Lichtmeister_Shutterstock_72368845
Oqema has acquired Stera Chemicals © Lichtmeister_Shutterstock_72368845

Company

Logo:

OQEMA AG

Schlossstrasse 39
41352 Korschenbroich
Germany

Company contact







Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.